201,152 Shares in Sociedad Química y Minera de Chile S.A. (NYSE:SQM) Acquired by Woodline Partners LP

Woodline Partners LP acquired a new stake in Sociedad Química y Minera de Chile S.A. (NYSE:SQM - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 201,152 shares of the basic materials company's stock, valued at approximately $7,314,000. Woodline Partners LP owned approximately 0.07% of Sociedad Química y Minera de Chile as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Manning & Napier Advisors LLC purchased a new position in Sociedad Química y Minera de Chile in the 4th quarter valued at about $120,395,000. Nuveen Asset Management LLC purchased a new position in shares of Sociedad Química y Minera de Chile during the fourth quarter valued at approximately $35,832,000. Northern Trust Corp grew its stake in Sociedad Química y Minera de Chile by 367.9% in the 4th quarter. Northern Trust Corp now owns 293,799 shares of the basic materials company's stock worth $10,683,000 after acquiring an additional 231,010 shares during the period. Van ECK Associates Corp raised its holdings in Sociedad Química y Minera de Chile by 28.4% in the 4th quarter. Van ECK Associates Corp now owns 804,913 shares of the basic materials company's stock valued at $29,267,000 after acquiring an additional 177,898 shares during the last quarter. Finally, Grantham Mayo Van Otterloo & Co. LLC lifted its stake in shares of Sociedad Química y Minera de Chile by 5.7% during the 4th quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 3,302,897 shares of the basic materials company's stock worth $120,093,000 after purchasing an additional 177,323 shares during the period. Institutional investors and hedge funds own 12.41% of the company's stock.

Sociedad Química y Minera de Chile Trading Down 2.7%

Shares of SQM stock traded down $0.89 during mid-day trading on Wednesday, hitting $31.83. 627,978 shares of the company's stock were exchanged, compared to its average volume of 1,105,247. The stock has a market cap of $9.09 billion, a price-to-earnings ratio of -28.67, a PEG ratio of 5.00 and a beta of 1.11. The stock has a 50-day simple moving average of $35.82 and a two-hundred day simple moving average of $38.02. Sociedad Química y Minera de Chile S.A. has a fifty-two week low of $31.27 and a fifty-two week high of $48.90. The company has a quick ratio of 2.05, a current ratio of 2.94 and a debt-to-equity ratio of 0.74.

Sociedad Química y Minera de Chile (NYSE:SQM - Get Free Report) last issued its quarterly earnings results on Wednesday, May 28th. The basic materials company reported $0.48 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.65 by ($0.17). Sociedad Química y Minera de Chile had a positive return on equity of 16.12% and a negative net margin of 6.74%. The business had revenue of $1.04 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same period in the previous year, the business posted ($3.04) earnings per share. The firm's quarterly revenue was down 4.4% on a year-over-year basis. Equities analysts expect that Sociedad Química y Minera de Chile S.A. will post -1.31 EPS for the current fiscal year.

About Sociedad Química y Minera de Chile

Sociedad Química y Minera de Chile SA operates as a mining company worldwide. The company offers specialty plant nutrients, including sodium potassium nitrate, specialty blends, and other specialty fertilizers under Ultrasol, Qrop, Speedfol, Allganic, Ultrasoline, ProP, and Prohydric brands. It also provides iodine and its derivatives for use in medical, agricultural, industrial, and human and animal nutrition products comprising x-ray contrast media, biocides, antiseptics and disinfectants, pharmaceutical intermediates, polarizing films for LCD and LED screens, chemicals, organic compounds, and pigments, as well as added to edible salt to prevent iodine deficiency disorders.